Evidence map›Paper›PMID 18358838›Full record

ArticleFEBS letters2008

Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.

Jianfeng Liu, Daret K St Clair, Xin Gu, Yunfeng Zhao

Open access · bronzeAbstract read
In one paragraph

Article in FEBS letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Mitochondrial superoxide dismutase--signals of distinction.Anti-cancer agents in medicinal chemistry · 2011
    Review
  14. Article
  15. Article
  16. Watching the watcher: regulation of p53 by mitochondria.Future oncology (London, England) · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jianfeng LiuDepartment of Pharmacology, Toxicology and Neuroscience, LSU Health Sciences Center, Shreveport, LA 71130, USA.
Daret K St Clair
Xin Gu
Yunfeng Zhao
Louisiana State University Health Sciences Center Shreveport · USUniversity of Kentucky · US

Funding

Mitochondrial translocation of p53 and its interaction with manganese superoxide R03CA128077 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHAO, YUNFENG · 2007 to 2008
$147k
NCI NIH HHS R03 CA128077NCI NIH HHS R03CA128077
6 · The paper itself

Abstract

The tumor suppressor p53 can translocate into mitochondria and activate apoptosis. Here we studied whether p53 mitochondrial translocation and subsequent apoptosis were affected by blocking mitochondrial permeability transition pore using cyclosporine A (CsA) and bongkrekic acid (BA) in skin epidermal JB6 cells and skin tissues. Our results demonstrated that CsA and BA blocked TPA-induced p53 translocation, leading to protection against the loss of mitochondrial membrane potential and Complex I activity, and eventually suppression of apoptosis. Thus, our results suggest that mitochondrial permeability transition is required for p53 mitochondrial translocation.

Indexed as

AnimalsBongkrekic AcidCell LineCyclosporineMembrane PotentialsMiceMice, Inbred DBAMitochondriaProtein TransportSkin NeoplasmsTetradecanoylphorbol AcetateTumor Suppressor Protein p53Bongkrekic AcidCyclosporineTetradecanoylphorbol AcetateTumor Suppressor Protein p53

Identifiers

PMID18358838
PMCPMC2367455
OpenAlexW2059125777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.